Laurie Beitz MD

Company: Umoja Biopharma

Job title: Senior Director, Discovery

Seminars:

VivoVec™ Generates Potent CAR-T-Cells In Vivo For the Potential Treatment of Autoimmune Diseases & Cancers 4:00 pm

Umoja is developing the VivoVec™ platform of therapeutics designed to be administered directly to patients resulting in the generation of CAR-T-cells in vivo to treat autoimmune diseases and cancers Modeling in non-human primates has demonstrated the ability of VivoVec™ to generate highly functional B-cell targeting CAR-T-cells in vivo that drive B-cell depletion and immune reset…Read more

day: Conference Day One P3